ArticleInternational journal of ophthalmology2014

Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization.

Halil Ibrahim Onder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.